2-(5-((2-(benzo[d]thiazol-2-ylamino)-2-oxoethyl)thio)-4H-1,2,4-triazol-3-yl)benzoic acid

ID: ALA3577963

Chembl Id: CHEMBL3577963

PubChem CID: 122178133

Max Phase: Preclinical

Molecular Formula: C18H13N5O3S2

Molecular Weight: 411.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CSc1nnc(-c2ccccc2C(=O)O)[nH]1)Nc1nc2ccccc2s1

Standard InChI:  InChI=1S/C18H13N5O3S2/c24-14(20-17-19-12-7-3-4-8-13(12)28-17)9-27-18-21-15(22-23-18)10-5-1-2-6-11(10)16(25)26/h1-8H,9H2,(H,25,26)(H,19,20,24)(H,21,22,23)

Standard InChI Key:  XDAKTDQGVCHONK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3577963

    ---

Associated Targets(non-human)

ccrA Beta-lactamase type II (170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-lactamase L1 (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
imiS Beta-lactamase (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
spm-1 Beta-lactamase IMP-1 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.47Molecular Weight (Monoisotopic): 411.0460AlogP: 3.51#Rotatable Bonds: 6
Polar Surface Area: 120.86Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.21CX Basic pKa: 1.43CX LogP: 3.18CX LogD: -0.31
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -2.26

References

1. Yang SK, Kang JS, Oelschlaeger P, Yang KW..  (2015)  Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.,  (4): [PMID:25893049] [10.1021/ml500534c]

Source